Koninklijke DSM N.V. 3
3 · AMYRIS, INC. · Filed Jul 17, 2017
Insider Transaction Report
Form 3
AMYRIS, INC.AMRS
DSM International B.V.
10% Owner
Holdings
- (indirect: See footnote)
Warrants (right to buy)
Exercise: $0.52From: 2017-07-07Exp: 2022-07-07→ Common Stock (1,984,058 underlying) - (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (3,968,116 underlying) - (indirect: See footnote)
Warrants (right to buy)
Exercise: $0.62From: 2017-07-07Exp: 2022-07-07→ Common Stock (1,984,058 underlying)
Footnotes (2)
- [F1]Each share of Series B preferred stock is convertible at any time at the option of the holder into Common Stock of the Issuer on an approximately 1-to-158.7 basis. The Series B preferred stock has no expiration date.
- [F2]The securities reported herein are held of record by DSM International B.V., which is a wholly owned subsidiary of Koninklijke DSM N.V. Accordingly, Koninklijke DSM N.V. may be deemed to share beneficial ownership of the securities held of record by DSM International. Koninklijke DSM N.V. is a publicly traded company with securities listed on the Amsterdam Stock Exchange.